Serveur d'exploration sur les variants du Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.

Identifieur interne : 000093 ( Main/Exploration ); précédent : 000092; suivant : 000094

The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.

Auteurs : Danielle C. Groves [Royaume-Uni] ; Sarah L. Rowland-Jones [Royaume-Uni] ; Adrienn Angyal [Royaume-Uni]

Source :

RBID : pubmed:33199022

Abstract

The development of the SARS-CoV-2 pandemic has prompted an extensive worldwide sequencing effort to characterise the geographical spread and molecular evolution of the virus. A point mutation in the spike protein, D614G, emerged as the virus spread from Asia into Europe and the USA, and has rapidly become the dominant form worldwide. Here we review how the D614G variant was identified and discuss recent evidence about the effect of the mutation on the characteristics of the virus, clinical outcome of infection and host immune response.

DOI: 10.1016/j.bbrc.2020.10.109
PubMed: 33199022
PubMed Central: PMC7643658


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.</title>
<author>
<name sortKey="Groves, Danielle C" sort="Groves, Danielle C" uniqKey="Groves D" first="Danielle C" last="Groves">Danielle C. Groves</name>
<affiliation wicri:level="1">
<nlm:affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX</wicri:regionArea>
<wicri:noRegion>S102RX</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rowland Jones, Sarah L" sort="Rowland Jones, Sarah L" uniqKey="Rowland Jones S" first="Sarah L" last="Rowland-Jones">Sarah L. Rowland-Jones</name>
<affiliation wicri:level="1">
<nlm:affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom. Electronic address: s.l.rowland-jones@sheffield.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX</wicri:regionArea>
<wicri:noRegion>S102RX</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Angyal, Adrienn" sort="Angyal, Adrienn" uniqKey="Angyal A" first="Adrienn" last="Angyal">Adrienn Angyal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX</wicri:regionArea>
<wicri:noRegion>S102RX</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33199022</idno>
<idno type="pmid">33199022</idno>
<idno type="doi">10.1016/j.bbrc.2020.10.109</idno>
<idno type="pmc">PMC7643658</idno>
<idno type="wicri:Area/Main/Corpus">000099</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000099</idno>
<idno type="wicri:Area/Main/Curation">000099</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000099</idno>
<idno type="wicri:Area/Main/Exploration">000099</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.</title>
<author>
<name sortKey="Groves, Danielle C" sort="Groves, Danielle C" uniqKey="Groves D" first="Danielle C" last="Groves">Danielle C. Groves</name>
<affiliation wicri:level="1">
<nlm:affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX</wicri:regionArea>
<wicri:noRegion>S102RX</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rowland Jones, Sarah L" sort="Rowland Jones, Sarah L" uniqKey="Rowland Jones S" first="Sarah L" last="Rowland-Jones">Sarah L. Rowland-Jones</name>
<affiliation wicri:level="1">
<nlm:affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom. Electronic address: s.l.rowland-jones@sheffield.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX</wicri:regionArea>
<wicri:noRegion>S102RX</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Angyal, Adrienn" sort="Angyal, Adrienn" uniqKey="Angyal A" first="Adrienn" last="Angyal">Adrienn Angyal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX</wicri:regionArea>
<wicri:noRegion>S102RX</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Biochemical and biophysical research communications</title>
<idno type="eISSN">1090-2104</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The development of the SARS-CoV-2 pandemic has prompted an extensive worldwide sequencing effort to characterise the geographical spread and molecular evolution of the virus. A point mutation in the spike protein, D614G, emerged as the virus spread from Asia into Europe and the USA, and has rapidly become the dominant form worldwide. Here we review how the D614G variant was identified and discuss recent evidence about the effect of the mutation on the characteristics of the virus, clinical outcome of infection and host immune response.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">33199022</PMID>
<DateRevised>
<Year>2020</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1090-2104</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Nov</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>Biochemical and biophysical research communications</Title>
<ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
</Journal>
<ArticleTitle>The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">S0006-291X(20)32038-6</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2020.10.109</ELocationID>
<Abstract>
<AbstractText>The development of the SARS-CoV-2 pandemic has prompted an extensive worldwide sequencing effort to characterise the geographical spread and molecular evolution of the virus. A point mutation in the spike protein, D614G, emerged as the virus spread from Asia into Europe and the USA, and has rapidly become the dominant form worldwide. Here we review how the D614G variant was identified and discuss recent evidence about the effect of the mutation on the characteristics of the virus, clinical outcome of infection and host immune response.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Groves</LastName>
<ForeName>Danielle C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo>
<Affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rowland-Jones</LastName>
<ForeName>Sarah L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom. Electronic address: s.l.rowland-jones@sheffield.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Angyal</LastName>
<ForeName>Adrienn</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Florey Institute for Host-Pathogen Interactions and the Department of Infection, Immunity and Cardiovascular Science (IICD), Sheffield University Medical School, Beech Hill Road, Sheffield, S. Yorkshire, S102RX, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Biochem Biophys Res Commun</MedlineTA>
<NlmUniqueID>0372516</NlmUniqueID>
<ISSNLinking>0006-291X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Mutation</Keyword>
<Keyword MajorTopicYN="N">Neutralising antibody</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Spike</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>10</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>10</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>5</Hour>
<Minute>51</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>11</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>11</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33199022</ArticleId>
<ArticleId IdType="pii">S0006-291X(20)32038-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.bbrc.2020.10.109</ArticleId>
<ArticleId IdType="pmc">PMC7643658</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31978945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 May 14;181(4):914-921.e10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32155444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Aug 20;182(4):812-827.e19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32697968</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Nov;81(22):12135-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17804504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 May 28;181(5):990-996.e5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32386545</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Sep 3;182(5):1284-1294.e9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32730807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Jul 17;369(6501):330-333</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32366695</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Oct 29;183(3):739-751.e8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32991842</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9436-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26159422</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 May;581(7807):215-220</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32225176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 May 14;181(4):894-904.e9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32275855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Pract. 2020 Aug;74(8):e13525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32374903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2008 Nov;4(11):e1000197</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18989460</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2020 Nov;21(11):1336-1345</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32887977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Oct 26;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33106671</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Groves, Danielle C" sort="Groves, Danielle C" uniqKey="Groves D" first="Danielle C" last="Groves">Danielle C. Groves</name>
</noRegion>
<name sortKey="Angyal, Adrienn" sort="Angyal, Adrienn" uniqKey="Angyal A" first="Adrienn" last="Angyal">Adrienn Angyal</name>
<name sortKey="Rowland Jones, Sarah L" sort="Rowland Jones, Sarah L" uniqKey="Rowland Jones S" first="Sarah L" last="Rowland-Jones">Sarah L. Rowland-Jones</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidVariantV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000093 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000093 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidVariantV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33199022
   |texte=   The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33199022" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidVariantV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Jan 26 18:10:18 2021. Site generation: Tue Jan 26 18:10:59 2021